Fundraising Fox
Ukko
Mountain View, US · Founded 2016 · Delaware corporation · 58 employees on LinkedIn · 7 known investors
Find your way into Ukko
Sign up to see every warm intro you have to Ukko
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ukko team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform. It applies AI and protein micro-engineering to create modified allergens that retrain the immune system to tolerate the allergen without triggering an allergic response.
Founders & leadership
Ukko was founded in 2016 by Anat Binur and Yanay Ofran.
Board
Investors · 7
How we know: Israel Biotech Fund's portfolio page · Not right? Tell us
How we know: Khosla Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Sanara Capital's portfolio page · Not right? Tell us
How we know: Western Technology Investment's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · bayer.com · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements$47.7M disclosed across 2 rounds · 2017–2021
- $40MSeries BJan 2021 · 3 sources
Leaps by Bayer (lead)
Source ↗
▶$7.7MraisedJul 2017 · 5 investors · OtherRule 506(b)
- Anat BinurExecutive Officer, Director
- Yanay OfranDirector
- Scott BradyDirector
- Samir KaulDirector
- Offering amount
- $7.7M
- Amount sold
- $7.7M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Ukko went on to found or lead other companies.
Frequently asked questions
- What does Ukko do?
- Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform. It applies AI and protein micro-engineering to create modified allergens that retrain the immune system to tolerate the allergen without triggering an allergic response.
- Who founded Ukko?
- Ukko was founded by Anat Binur, Yanay Ofran in 2016.
- Who are Ukko's investors?
- Ukko's investors include Israel Biotech Fund, Khosla Ventures, Sanara Capital, Western Technology Investment, Fall Line Capital, Leaps by Bayer, PeakBridge VC.
- How much funding has Ukko raised?
- Ukko has disclosed $47.7M raised across 2 rounds.
- Where is Ukko headquartered?
- Ukko is headquartered in Mountain View, US.